相关实验视频
Updated: May 5, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
在阴道癌终极放射治疗中,体积基剂量和瘤局部控制之间的剂量反应关系
Zhiqiang Wang1, Xin Guo1, Hongfu Zhao2
1Department of Radiation Oncology, China-Japan Union Hospital of Jilin University, No. 126, Xiantai Street, Changchun, 130033, PR China.
BMC cancer
|June 8, 2024
概括
这项研究发现,高风险临床目标体积 (HR-CTV) D90和阴道癌的局部控制之间存在显著的剂量反应关系. 达到79.0 GyEQD2,10的D90与90%的2年局部控制有关.
科学领域:
- 辐射瘤学 辐射瘤学
- 妇科瘤学 妇科瘤学
- 临床瘤学临床瘤学
背景情况:
- 阴道癌症的治疗依赖于放射治疗,但最佳剂量处方仍在争论中.
- 建立清晰的剂量反应关系对于改善治疗结果至关重要.
研究的目的:
- 为了确定基于体积的剂量和阴道癌症患者的局部控制之间的关系.
- 确定实现特定局部控制率所需的剂量.
主要方法:
- 在PubMed,科学网和科克兰图书馆进行系统的文献搜索,截至2023年8月.
- 试管回归分析,以评估基于体积的剂量 (D90) 与局部对照之间的相关性.
- 对各种患者和治疗因素进行了子组分析.
主要成果:
- 分析了18项研究,其中包括879名患者 (293名原发性,573名复发性阴道癌).
- 在HR-CTV (或CTV) D90和2年/3年的局部对照 (P=0.013/0.014) 之间发现了显著的关联.
- 79.0 GyEQD2,10 (95% CI: 75.3-96.6 GyEQD2,10) 的D90预测了90%的2年当地控制.
结论:
- 阴道癌的局部控制显著依赖于HR-CTV (或CTV) D90.
- 建议通过多中心临床试验进行进一步验证,以确认这些剂量反应发现.
相关概念视频
Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Dose-Response Relationship: Potency and Efficacy
6.8K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.8K
Dose Size and Dosing Frequency: Determination Methods
817
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
817
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
188
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly...
188
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
212
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates...
212
Dose Response Curve: Conventional Versus Nonmonotonic
383
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
383

